Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Royce Smaller-Companies Growth Fund Service Class (RYVPX)

Net Asset Value
1 Day
Overall Morningstar Rating
Small growth
Style or Category
No Load
Sales Expenses
Expense Ratio
Above Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term growth of capital. The fund's investment adviser invests the fund's assets primarily in equity securities of companies with stock market capitalizations up to $7.5 billion that Royce believes have above-average growth prospects. Normally- the fund invests at least 80% of its net assets in equity securities of companies with stock market capitalizations up to $7.5 billion. Although the fund normally focuses on securities of U.S. companies- it may invest up to 25% of its net assets (measured at the time of investment) in securities of companies headquartered in foreign countries.


1 month+2.24% 3 years+10.21%
3 months+3.10% 5 years+11.53%
1 year+19.16% Since inception+11.44%
Data through --

Peer Comparisonvs. Small growth

Performance 5-yr return+11.53%+13.96%
Expense ratio1.51%1.28%
Risk 5 year sharpe ratio0.821.01
Net assets$368.3M$1.0B
Average market cap$1.8B$3.8B
Average P/E27.628.5
Portfolio turnover59%59%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyRoyce
Fund manager & tenureJames (Chip) Skinner / 14 Years
Minimal initial investment$2,000.00
Minimum IRA investment$1,000.00


U.S. stock77.70%
International stock9.12%
Fixed income4.37%
Top 5 Sectors
Portfolio weighting
Industrial materials 20.73%
Financial service 18.96%
Hardware 14.48%
Business service 11.16%
Consumer service 10.62%
Top 10 Holdings
Portfolio weighting
IPGP IPG Photonics Corp1.95%
PLUS ePlus inc1.91%
QADA QAD Inc1.86%
SQ Square Inc1.73%
-- 1.70%
MTLS Materialise NV1.68%
NEO Neogenomics Inc1.65%
ALB Albemarle Corp1.63%
PCTY Paylocity Holding Corp1.63%
SUPN Supernus Pharmaceuticals Inc1.62%